Table 2 Univariate relationships between the demographic and clinical characteristics and the outcome
Outcome + n=17 | Outcome − n=31 | OR (95% CI) | Effect size** | |
|---|---|---|---|---|
Sex | 1.13 (0.29–4.49) | 0.059 | ||
Male | 13 (36.1) | 23 (63.9) | ||
Female | 4 (33.3) | 8 (66.7) | ||
Diabetes mellitus | 0.51 (0.15–1.730) | 0.317 | ||
Yes | 6 (27.3) | 16 (72.7) | ||
No | 11 (42.3) | 15 (57.7) | ||
Hypertension | 3.37 (0.80–4.18) | 0.345 | ||
Yes | 14 (43.6) | 13 (56.4) | ||
No | 3 (18.8) | 13 (81.2) | ||
ACEI/ARB | 0.93 (0.28–3.03) | 0.073 | ||
Yes | 9 (34.6) | 17 (65.4) | ||
No | 8 (38.1) | 13 (61.9) | ||
History of renal failure | 1.24 (0.19–8.29) | 0.105 | ||
Yes | 2 (40) | 3 (60) | ||
No | 15 34.9) | 28 (65.1) | ||
LVEF, number of patients/total patients | 0.71 (0.15–3.50) | 0.158 | ||
> 35% | 9/26 (34.6) | 17/26 (65.4) | ||
≤ 35% | 3/11 (27.3) | 8/11 (72.7) | ||
LVEF*, n=37 | 52 (29, 55) | 43 (32, 55) | 1.01 (90.96–1.07) | 0.110 |
BUN/Cr > 20 | 1.87 (90.51–6.88) | 0.305 | ||
Yes | 6 (46.2) | 7 (53.8) | ||
No | 11 (31.4) | 24 (68.6) | ||
Age, year | 61.9 ± 16.2 | 60.3 ± 11.2 | 1.01 (0.96–1.06) | 0.122 |
BMI, n=44 | 28.8 ± 5.7 | 27.4 ± 4.5 | 1.06 (0.93–1.21) | 0.284 |
hs-CRP* | 7.4 (2.8, 12.2) | 3.2 (0.7, 8.7) | 1.07 (0.97–1.02) | 0.327 |
CT score* | 6 (2.5, 11) | 1 (0, 2) | 1.38 (1.12–1.70) | 0.634 |
LVEF*, n=37 | 52 (29, 55) | 43 (32, 55) | 1.01 (90.96–1.07) | 0.110 |